Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care.

ABSTRACT:

Background

Anticancer treatment exposes patients to negative consequences such as increased toxicity and decreased quality of life, and there are clear guidelines recommending limiting use of aggressive anticancer treatments for patients near end of life. The aim of this study is to investigate the association between anticancer treatment given during the last 30 days of life and adverse events contributing to death and elucidate how adverse events can be used as a measure of quality and safety in end-of-life cancer care.

Methods

Retrospective cohort study of 247 deceased hospitalised cancer patients at three hospitals in Norway in 2012 and 2013. The Global Trigger Tool method were used to identify adverse events. We used Poisson regression and binary logistic regression to

SUBMITTER: Haukland EC 

PROVIDER: S-EPMC7265218 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature